Delivery Order SPE2DR25D1004-SPE2DR26FSVC8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.41 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (90-count units) with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,749.28 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract was awarded on July 22, 2025, with firm fixed pricing and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pioglitazone HCL 30 mg tablets in a quantity of 500 units. This is a firm fixed-price delivery order valued at $1,502.62, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pioglitazone HCL 15 mg tablets in a quantity of 90 count, valued at $1,904.05. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of October 22, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,139.20 to supply Pioglitazone HCL 15 mg tablets (quantity: 90 count) with delivery to the company's distribution facility in Conshohocken, Pennsylvania. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $3,170.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Pioglitazone HCL 30 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order is valued at $7,265.38 and is scheduled for completion by September 29, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $6,417.35. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pioglitazone is a diabetes management medication commonly...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSVC8Delivery Order
The Defense Logistics Agency awarded a $2,295.38 delivery order to AmerisourceBergen Drug Corp for Pioglitazone HCL 15 mg tablets in unit dose packaging of 100 tablets. This is a firm fixed price, non-set-aside contract with a completion date of November 19, 2025, and performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive DLA pharmaceutical prime vendor contract. The SPE2DX IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency and U.S. Coast Guard. This delivery order for the diabetes medication Pioglitazone represents a routine fulfillment under the broader contract vehicle supporting federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/18/25 |